FDA Approved: REGLAN — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Reglan (metoclopramide hydrochloride) submitted by ANI Pharmaceuticals, Inc. for NDA 017854.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Gastroparesis
• Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• Reglan (metoclopramide)

Snippet

SUPPL AP for REGLAN (METOCLOPRAMIDE HYDROCHLORIDE)